Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

What is the purpose of this trial?

This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

National Cancer Institute

Start Date: 06/01/2016

End Date: 06/01/2021

Last Updated: 02/22/2018

Study HIC#: 1507016130